We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$7.12B
AUM Growth
+$672M
Cap. Flow
+$202M
Cap. Flow %
2.84%
Top 10 Hldgs %
30.81%
Holding
2,906
New
717
Increased
1,154
Reduced
469
Closed
172

Sector Composition

Rank Sector Weight
1 Technology 11.84%
2 Financials 7.35%
3 Industrials 4.85%
4 Consumer Discretionary 3.55%
5 Healthcare 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIVB icon
2626
Civista Bancshares
CIVB
$594M
$93 ﹤0.01%
+4
New +$87
PEBO icon
2627
Peoples Bancorp
PEBO
$1.45B
$92 ﹤0.01%
+3
New +$88
TRDA icon
2628
Entrada Therapeutics
TRDA
$227M
$88 ﹤0.01%
+13
New +$105
LCUT icon
2629
Lifetime Brands
LCUT
$199M
$87 ﹤0.01%
+17
New +$63
STRO icon
2630
Sutro Biopharma
STRO
$379M
$87 ﹤0.01%
+12
New +$98
PGY icon
2631
Pagaya Technologies
PGY
$1.32B
$86 ﹤0.01%
+4
New +$57
MTSR
2632
DELISTED
Metsera Inc
MTSR
$86 ﹤0.01%
+3
New +$74
EWCZ
2633
DELISTED
European Wax Center
EWCZ
$85 ﹤0.01%
+15
New +$68
SLND icon
2634
Southland Holdings
SLND
$33.6M
$84 ﹤0.01%
+20
New +$71
SPHR icon
2635
Sphere Entertainment
SPHR
$4.88B
$84 ﹤0.01%
2
TBCH
2636
Turtle Beach Corp
TBCH
$239M
$83 ﹤0.01%
+6
New +$72
LIND icon
2637
Lindblad Expeditions
LIND
$1.76B
$82 ﹤0.01%
7
MTRX icon
2638
Matrix Service
MTRX
$347M
$82 ﹤0.01%
+6
New +$72
MSGE icon
2639
Madison Square Garden
MSGE
$3.61B
$80 ﹤0.01%
2
NIO icon
2640
NIO
NIO
$11.3B
$79 ﹤0.01%
23
BIOA
2641
BioAge Labs
BIOA
$968M
$75 ﹤0.01%
+18
New +$73
ABOS icon
2642
Acumen Pharmaceuticals
ABOS
$154M
$74 ﹤0.01%
+63
New +$68
ALXO icon
2643
ALX Oncology
ALXO
$273M
$74 ﹤0.01%
+177
New +$89
KFY icon
2644
Korn Ferry
KFY
$3.98B
$74 ﹤0.01%
+1
New +$67
FCEL icon
2645
FuelCell Energy
FCEL
$1.7B
$73 ﹤0.01%
13
ASPN icon
2646
Aspen Aerogels
ASPN
$387M
$72 ﹤0.01%
+12
New +$69
RNGR icon
2647
Ranger Energy Services
RNGR
$373M
$72 ﹤0.01%
+6
New +$72
ENTA icon
2648
Enanta Pharmaceuticals
ENTA
$372M
$69 ﹤0.01%
+9
New +$54
IGMS
2649
DELISTED
IGM Biosciences
IGMS
$69 ﹤0.01%
+61
New +$75
FNKO icon
2650
Funko
FNKO
$323M
$67 ﹤0.01%
+14
New +$64

Similar funds

Clearstead Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Clearstead Advisors held 2,906 positions worth $7.12B, up 10% from $6.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors's Q2 2025 filing shows 717 new, 1,154 increased, 469 reduced and 172 closed positions. Its largest new stake was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 9,578 shares worth $944K. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Clearstead Advisors's largest Q2 2025 buy was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 9,578 shares worth $944K.
  • Clearstead Advisors added most to iShares Broad USD High Yield Corporate Bond ETF in Q2 2025, an estimated $22M increase.
  • Clearstead Advisors's biggest Q2 2025 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $21.3M.
  • Clearstead Advisors fully exited Invesco Senior Loan ETF in Q2 2025, selling an estimated $7.86M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.12B portfolio in Q2 2025.
  • Clearstead Advisors opened 717 new positions and closed 172 in Q2 2025.
  • Clearstead Advisors's portfolio value rose 10% quarter-over-quarter to $7.12B.

Based on Clearstead Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.